Current and future therapeutic strategies for treatment of blastomycosis

Bibliography

• Klein BS, Vergeront JM, DiSalvo AF, et al. Two outbreaks of blastomycosis along rivers in Wisconsin. Isolation of Blastomyces dermatitidis from riverbank soil and evidence of its transmission along waterways. Am Rev Respir Dis 1987;136:1333-8
   PubMed Web of Science ®Google Scholar
• Dworkin MS, Duckro AN, Proia L, et al. The epidemiology of blastomycosis in Illinois and factors associated with death. Clin Infect Dis 2005;41:e107-11
   PubMed Web of Science ®Google Scholar
• Cano MV, Ponce-de-Leon GF, Tippen S, et al. Blastomycosis in Missouri: epidemiology and risk factors for endemic disease. Epidemiol Infect 2003;131:907-14
   PubMed Web of Science ®Google Scholar
• Crampton TL, Light RB, Berg GM, et al. Epidemiology and clinical spectrum of blastomycosis diagnosed at Manitoba hospitals. Clin Infect Dis 2002;34:1310-16
   PubMed Web of Science ®Google Scholar
• The Centers for Disease Control and Prevention. Blastomycosis-Wisconsin, 1986-1995. MMWR Morb Mortal Wkly Rep 1996;45:601-3
   PubMedGoogle Scholar
• Roy M, Benedict K, Deak E, et al. A large community outbreak of blastomycosis in Wisconsin with geographic and ethnic clustering. Clin Infect Dis 2013;57(5):655-62
   PubMed Web of Science ®Google Scholar
• Arnett MV, Fraser SL, Grbach VX. Pulmonary blastomycosis diagnosed in Hawaii. Southeast Asian J Trop Med Public Health 2008;39(4):701-5
   PubMedGoogle Scholar
• De Groote MA, Bjerke R, Smith H, et al. Expanding epidemiology of blastomycosis: clinical features and investigation of 2 cases in Colorado. Clin Infect Dis 2000;30:582-4
   PubMed Web of Science ®Google Scholar
• DiSalvo AF. The ecology of Blastomyces dermatitidis. Current Topics in Infectious Disease. Pledum Publishing Corp., 1992. p. 43-73
   Google Scholar
• Choptiany M, Wiebe L, Limerick B, et al. Risk factors for acquisition of endemic blastomycosis. Can J Infect Dis Med Microbiol 2009;20(4):117-21
   PubMed Web of Science ®Google Scholar
• Bradsher RW. Water and blastomycosis: don't blame beaver. Am Rev Respir Dis 1987;136:1324-6
   PubMedGoogle Scholar
• Baumgardner DJ, Knavel EM, Steber D, et al. Geographic distribution of human blastomycosis cases in Milwaukee, Wisconsin, USA: association with urban watersheds. Mycopathologia 2006;161:275-82
   PubMed Web of Science ®Google Scholar
• Lemke MA, Baumgardner DJ, Brummitt CF, et al. Blastomycosis in urban southeastern Wisconsin. WMJ 2009;108(8):407-10
   PubMedGoogle Scholar
• Ehni W. Endogenous reactivation in blastomycosis. Am J Med 1989;86:831-2
   PubMed Web of Science ®Google Scholar
• Pappas PG, Pottage JC, Powderly WG, et al. Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1992;116:847-53
   PubMed Web of Science ®Google Scholar
• Pappas PG, Dismukes WE. Blastomycosis: gilchrist's disease revisited. Curr Clin Top Infect Dis 2002;22:61-77
   PubMedGoogle Scholar
• Pappas PG, Threlkeld MG, Bedsole GD, et al. Blastomycosis in immunocompromised patients. Medicine (Baltimore) 1993;72:311-25
   PubMed Web of Science ®Google Scholar
• Butka BJ, Bennett SR, Johnson AC. Disseminated inoculation blastomycosis in a renal transplant recipient. Am Rev Respir Dis 1984;130:1180-3
   PubMedGoogle Scholar
• Serody JS, Mill MR, Detterbeck FC, et al. Blastomycosis in transplant recipients: report of a case and review. Clin Infect Dis 1993;16:54-8
   PubMed Web of Science ®Google Scholar
• Winkler S, Stanek G, Hubsch P, et al. Pneumonia due to blastomyces dermatitidis in a European renal transplant recipient. Nephrol Dial Transplant 1996;11:1376-9
   PubMed Web of Science ®Google Scholar
• Gauthier GM, Safdar N, Klein BS, et al. Blastomycosis in solid organ transplant recipients. Transpl Infect Dis 2007;9:310-17
   PubMed Web of Science ®Google Scholar
• FDA. Tumor necrosis factor-alpha blockers (TNF blockers), Cimzia (certolizumab pegol), Enbrel (etanercept), Humira (adalimumab), and Remicade (infliximab). Alert September 2008
   Google Scholar
• Lekkala M, LeVine AM, Linke MJ, et al. Effect of lung surfactant collectins on bronchoalveolar macrophage interaction with Blastomyces dermatitidis: inhibition of tumor necrosis factor alpha production by surfactant protein D. Infect Immun 2006;74:4549-56
   PubMed Web of Science ®Google Scholar
• Sugar AM, Picard M. Macrophage- and oxidant-mediated inhibition of the ability of live Blastomyces dermatitidis conidia to transform to the pathogenic yeast phase: implications for the pathogenesis of dimorphic fungal infections. J Infect Dis 1991;163:371-5
   PubMed Web of Science ®Google Scholar
• Sarosi GA, Davies SF. Blastomycosis. Am Rev Respir Dis 1979;120:911-38
   PubMed Web of Science ®Google Scholar
• Harris JR, Blaney DD, Lindsley MD, et al. Blastomycosis in man after kinkajou bite. Emerg Infect Dis 2011;17(2):268-70
   PubMed Web of Science ®Google Scholar
• Larsh HW, Schwarz J. Accidental inoculation blastomycosis. Cutis 1977;19:334-7
   PubMed Web of Science ®Google Scholar
• Gnann JW, Bressler GS, Bodet CA, Avent CK. Human blastomycosis after a dog bite. Ann Intern Med 1983;98:48-9
   PubMed Web of Science ®Google Scholar
• Chang WL, Audet RG, Aizenstein BD, et al. T-cell epitopes and human leukocyte antigen restriction elements of an immunodominant antigen of Blastomyces dermatitidis. Infect Immun 2000;68:502-10
   PubMed Web of Science ®Google Scholar
• Morozumi PA, Brummer E, Stevens DA. Protection against pulmonary blastomycosis: correlation with cellular and humoral immunity in mice after subcutaneous nonlethal infection. Infect Immun 1982;37(2):670-8
   PubMed Web of Science ®Google Scholar
• Klein BS, Bradsher RW, Vergeront JM, Davis JP. Development of long-term specific cellular immunity after acute Blastomyces dermatitidis infection: assessments following a large point-source outbreak in Wisconsin. J Infect Dis 1990;161(1):97-101
   PubMed Web of Science ®Google Scholar
• Chapman SW, Lin AC, Hendricks KA, et al. Endemic blastomycosis in Mississippi: epidemiological and clinical studies. Semin Respir Infect 1997;12:219-28
   PubMedGoogle Scholar
• Lemos LB, Baliga M, Guo M. Acute respiratory distress syndrome and blastomycosis: presentation of nine cases and review of the literature. Ann Diagn Pathol 2001;5:1-9
   PubMedGoogle Scholar
• Vasquez JE, Mehta JB, Agrawal R, et al. Blastomycosis in northeast Tennessee. Chest 1998;114(2):436-43
   PubMed Web of Science ®Google Scholar
• Martynowicz MA, Prakash UB. Pulmonary blastomycosis: an appraisal of diagnostic techniques. Chest 2002;121:768-73
   PubMed Web of Science ®Google Scholar
• Richer SM, Smedema ML, Durkin MM, et al. Development of a highly sensitive and specific blastomycosis antibody enzyme immunoassay using Blastomyces dermatitidis surface protein BAD-1. Clin Vaccine Immunol 2014;21(2):143-6
   PubMedGoogle Scholar
• Durkin M, Witt J, LeMonte A, et al. Antigen assay with the potential to aid in diagnosis of blastomycosis. J Clin Microbiol 2004;42(10):4873-5
   PubMed Web of Science ®Google Scholar
• Mongkolrattanothai K, Peev M, Wheat L, Marcinak J. Urine antigen detection of blastomycosis in pediatric patients. Pediatr Infect Dis J 2006;25(11):1076-8
   PubMed Web of Science ®Google Scholar
• Hage CA, Knox KS, Davis TE, Wheat LJ. Antigen detection in bronchoalveolar lavage fluid for diagnosis of fungal pneumonia. Curr Opin Pulm Med 2011;17(3):167-71
   PubMed Web of Science ®Google Scholar
• Bariola JR, Perry P, Pappas PG. Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era. Clin Infect Dis 2010;50(6):797-804
   PubMed Web of Science ®Google Scholar
• Van Der Veer J, Lewis RJ, Emtiazjoo AM, et al. Cross-reactivity in the Platelia™ Aspergillus enzyme immunoassay caused by blastomycosis. Med Mycol 2012;50(4):396-8
   PubMed Web of Science ®Google Scholar
• Trumbull ML, Chesney TM. The cytological diagnosis of pulmonary blastomycosis. JAMA 1981;245:836-8
   PubMed Web of Science ®Google Scholar
• Bariola JR, Hage CA, Durkin M. Detection of Blastomyces dermatitidis antigen in patients with newly diagnosed blastomycosis. Diagn Microbiol Infect Dis 2011;69(2):187-91
   PubMed Web of Science ®Google Scholar
• Hatch WO, Scalarone GM. Development of a slide agglutination assay for detection of blastomycosis. Microbiol Immunol 2013;57(11):756-61
   PubMed Web of Science ®Google Scholar
• Sidamonidze K, Peck MK, Perez M, et al. Real-time PCR assay for identification of Blastomyces dermatitidis in culture and in tissue. J Clin Microbiol 2012;50(5):1783-6
   PubMed Web of Science ®Google Scholar
• Babady NE, Buckwalter SP, Hall L, et al. Detection of Blastomyces dermatitidis and Histoplasma capsulatum from culture isolates and clinical specimens by use of real-time PCR. J Clin Microbiol 2011;49(9):3204-8
   PubMed Web of Science ®Google Scholar
• Chapman SW, Dismukes WE, Proia LA, et al. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis 2008;46:1801-12
   PubMed Web of Science ®Google Scholar
• Lewis RE. Current concepts in antifungal pharmacology. Mayo Clin Proc 2011;86(8):805-17
   PubMed Web of Science ®Google Scholar
• Pappas PG, Bradsher RW, Kauffman CA, et al. Treatment of blastomycosis with higher doses of fluconazole. The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis 1997;25(2):200-5
   PubMed Web of Science ®Google Scholar
• Dismukes WE, Bradsher RW Jr, Cloud GC, et al. Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Am J Med 1992;93:489-97
   PubMed Web of Science ®Google Scholar
• Li RK, Ciblak MA, Nordoff N, et al. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum. Antimicrob Agents Chemother 2000;44:1734-6
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol 1998;36:2950-6
   PubMed Web of Science ®Google Scholar
• Sugar AM, Liu XP. In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis. Antimicrob Agents Chemother 1996;40:1314-16
   PubMed Web of Science ®Google Scholar
• Sugar AM, Liu XP. Efficacy of voriconazole in treatment of murine pulmonary blastomycosis. Antimicrob Agents Chemother 2001;45:601-4
   PubMed Web of Science ®Google Scholar
• Freifeld A, Proia LA, Andes D, et al. Voriconazole use for endemic fungal infections. Antimicrob Agents Chemother 2009;53(4):1648-51
   PubMed Web of Science ®Google Scholar
• Borgia SM, Fuller JD, Sarabia A, El-Helou P. Cerebral blastomycosis: a case series incorporating voriconazole in the treatment regimen. Med Mycol 2006;44(7):659-64
   PubMed Web of Science ®Google Scholar
• Lutsar I, Roffey S, Troke P. Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients. Clin Infect Dis 2003;37:728-32
   PubMed Web of Science ®Google Scholar
• Almony A, Kraus CL, Apte RS. Successful treatment of choroidal blastomycosis with oral administration of voriconazole. Can J Ophthalmol 2009;44(3):333-5
   Web of Science ®Google Scholar
• Neofytos D, Lombardi LR, Shields RK, et al. Administration of voriconazole in patients with renal dysfunction. Clin Infect Dis 2012;54(7):913-21
   PubMed Web of Science ®Google Scholar
• Oude Lashof AM, Sobel JD, Ruhnke M, et al. Safety and tolerability of voriconazole in patients with baseline renal insufficiency and candidemia. Antimicrob Agents Chemother 2012;56(6):3133-7
   PubMed Web of Science ®Google Scholar
• Andes D, Pascual A, Marchetti O. Antifungal therapeutic drug monitoring: established and emerging indications. Antimicrob Agents Chemother 2009;53(1):24-34
   PubMed Web of Science ®Google Scholar
• Rex JH, Stevens DA. Systemic antifungal agents. In: Mandel GL, editor, Principles and practice of infectious diseases. Elsevier, Philadelphia, PA; 2010. p. 549-63
   Google Scholar
• Boyd NK, Zoellner CL, Swancutt MA, et al. Utilization of omeprazole to augment subtherapeutic voriconazole concentrations for treatment of Aspergillus infections. Antimicrob Agents Chemother 2012;56(11):6001-2
   PubMed Web of Science ®Google Scholar
• Proia LA, Harnisch DO. Successful use of posaconazole for treatment of blastomycosis. Antimicrob Agents Chemother 2012;56(7):4029
   PubMed Web of Science ®Google Scholar
• Krishna G, Ma L, Martinho M, et al. A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteers. J Antimicrob Chemother 2012;67(11):2725-30
   PubMed Web of Science ®Google Scholar
• Falci DR, Pasqualotto AC. Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections. Infect Drug Resist 2013;6:163-74
   PubMedGoogle Scholar
• Gonzalez GM. In vitro activities of isavuconazole against opportunistic filamentous and dimorphic fungi. Med Mycol 2009;47(1):71-6
   PubMed Web of Science ®Google Scholar
• Ariano RE, Mitchelmore BR, Lagacé-Wiens PR, Zelenitsky SA. Successful treatment of pulmonary blastomycosis with continuously infused amphotericin B deoxycholate after failure with liposomal amphotericin B. Ann Pharmacother 2013;47(6):e26
   PubMed Web of Science ®Google Scholar
• Mardini J, Nguyen B, Ghannoum M. Treatment of chronic pulmonary blastomycosis with caspofungin. J Med Microbiol 2011;60:1875-8
   PubMed Web of Science ®Google Scholar
• Deepe GS Jr, Wüthrich M, Klein BS. Progress in vaccination for histoplasmosis and blastomycosis: coping with cellular immunity. Med Mycol 2005;43(5):381-9
   PubMed Web of Science ®Google Scholar
• Wüthrich M, Krajaejun T, Shearn-Bochsler V. Safety, tolerability, and immunogenicity of a recombinant, genetically engineered, live-attenuated vaccine against canine blastomycosis. Clin Vaccine Immunol 2011;18(5):783-9
   PubMedGoogle Scholar
• Tarr M, Marcinak J, Mongkolrattanothai K, et al. Blastomyces antigen detection for monitoring progression of blastomycosis in a pregnant adolescent. Infect Dis Obstet Gynecol 2007;2007:89059
   PubMedGoogle Scholar
• Sarosi GA, Davies SF, Phillips JR. Self-limited blastomycosis: a report of 39 cases. Semin Respir Infect 1986;1:40-4
   PubMedGoogle Scholar
• Hage CA, Knox KS, Wheat L. Endemic mycoses: overlooked causes of community acquired pneumonia. Respir Med 2012;106(6):769-76
   PubMed Web of Science ®Google Scholar
• Kralt D, Light B, Cheang M. Clinical characteristics and outcomes in patients with pulmonary blastomycosis. Mycopathologia 2009;167:115-24
   PubMed Web of Science ®Google Scholar
• Meyer KC, McManus EJ, Maki DG. Overwhelming pulmonary blastomycosis associated with the adult respiratory distress syndrome. N Engl J Med 1993;329:1231-6
   PubMed Web of Science ®Google Scholar
• Plamondon M, Lamontagne F, Allard C, Pépin J. Corticosteroids as adjunctive therapy in severe blastomycosis-induced acute respiratory distress syndrome in an immunosuppressed patient. J Clin Infect Dis 2010;51(1):e1-3
   PubMed Web of Science ®Google Scholar
• Lahm T, Neese S, Thornburg AT, et al. Corticosteroids for blastomycosis-induced ARDS. Chest 2008;133:1478-80
   PubMed Web of Science ®Google Scholar
• Dalton HJ, Hertzog JH, Hannan RL, et al. Extracorporeal membrane oxygenation for overwhelming Blastomyces dermatitidis pneumonia. Crit care 1999;3(4):91-4
   PubMed Web of Science ®Google Scholar
• Body BA. Cutaneous manifestations of systemic mycoses. Dermatol Clin 1996;14:125-35
   PubMed Web of Science ®Google Scholar
• Steck WD. Blastomycosis. Dermatol Clin 1989;7:241-50
   PubMed Web of Science ®Google Scholar
• Smith JA, Riddell J IV, Kauffman CA. Cutaneous manifestations of endemic mycoses. Curr Infect Dis Rep 2013;15(5):440-9
   PubMed Web of Science ®Google Scholar
• Moore RM, Green NE. Blastomycosis of bone. A report of six cases. J Bone Joint Surg Am 1982;64:1097-101
   PubMed Web of Science ®Google Scholar
• Morse HG, Nichol WP, Cook DM, et al. Central nervous system and genitourinary blastomycosis: confusion with tuberculosis. West J Med 1983;139:99-103
   PubMedGoogle Scholar
• Mochizuki K, Niwa Y, Ishida K, Kawakami H. Intraocular penetration of itraconazole in patient with fungal endophthalmitis. Int Ophthalmol 2013;33(5):579-81
   PubMed Web of Science ®Google Scholar
• Oppenheimer M, Embil JM, Black B, et al. Blastomycosis of bones and joints. South Med J 2007;100(6):570-8
   PubMed Web of Science ®Google Scholar
• Gonyea EF. The spectrum of primary blastomycotic meningitis: a review of central nervous system blastomycosis. Ann Neurol 1978;3:26-39
   PubMed Web of Science ®Google Scholar
• Bush JW, Wuerz T, Embil JM. Outcomes of persons with blastomycosis involving the central nervous system. Diagn Microbiol Infect Dis 2013;76(2):175-81
   PubMed Web of Science ®Google Scholar
• Ta M, Flowers SA, Rogers PD. The role of voriconazole in the treatment of central nervous system blastomycosis. Ann Pharmacother 2009;43(10):1696-700
   PubMed Web of Science ®Google Scholar
• Ward BA, Parent AD, Raila F. Indications for the surgical management of central nervous system blastomycosis. Surg Neurol 1995;43:379-88
   PubMedGoogle Scholar